2026-09-21
FDA Import Alerts and Research Supplies — 2026 Status
How Import Alerts work, why foreign facility registration matters, and what it means for imported material
USP Compendial Updates — What Changed and Why Suppliers Care
Recent chapter revisions relevant to sterile diluents and how suppliers adapt
Read the full piece →More from Research Chem Today
2026-09-18
Research Supply Market Consolidation — Who's Acquiring Whom in 2026
M&A activity in the research chemical space, quality implications of consolidation, what buyers should watch
2026-09-17
Good Distribution Practices (GDP) and Research Cold-Chain — What Applies
EU GDP guidelines applied to research supply; which elements are best practices vs regulatory requirements
2026-09-15
Patent Expiry Landscape for Peptide Therapeutics — 2026 Research Implications
Which blockbuster peptide drugs lose exclusivity through 2028, how it affects research supply pricing and availability
2026-09-11
Lab Insurance for Research Chemical Inventory — What's Covered
General liability vs professional vs product liability; what research-grade chemical inventory means for policy terms
2026-09-10
Bacteriostatic Water Expiry — What the Shelf Life Data Actually Shows
Benzyl alcohol stability over time, USP antimicrobial efficacy testing per <51>, post-open vs sealed shelf life
2026-09-08
Clinical Trial Supply Chain Lessons Applicable to Research Procurement
Risk-based qualification, comparator sourcing, documentation standards; adapting pharma practices to research scale
2026-09-07
Research Vendor Cold Storage Claims Compared — Verified vs Marketing
Which vendors document their -20°C / 2-8°C storage with temperature logs vs just stating it on the website
2026-09-04
AI-Assisted Adulteration Detection in Research Supply — Emerging Tools
ML-based HPLC-MS fingerprinting, spectral library matching, which labs are deploying it, cost implications
2026-09-03
DEA Scheduling Risk for Research Peptides — What's on the Watch List
Analogue Act, temporary scheduling orders, which compound classes are at elevated scheduling risk in 2026
2026-09-01
Credit Terms with Research Chemical Vendors — Risk and Opportunity
Net-30 availability, prepayment norms, escrow alternatives, what credit terms signal about vendor stability
2026-08-31
Peptide HS/HTS Codes for US Import — Classification Guide
HTS chapters 29 vs 35 for synthetic peptides, customs broker guidance, duty rates by classification
2026-08-29
QMS Adoption in Small Research Chemical Suppliers — What to Expect
ISO 9001 vs informal QMS, what audit-ready documentation looks like for a small supplier, green/yellow/red signals
2026-08-28
FDA 483 Observations in Research Supply — Trends to Watch
Analysis of recent 483s relevant to research-grade chemicals: sterility, labeling, documentation failures
2026-08-25
Compounding Pharmacy vs Research Supplier — The Regulatory Divide
503A vs 503B compounders vs research-use-only suppliers; what each can legally sell and to whom
2026-08-24
US Peptide Synthesis Reshoring — Quality and Supply Implications
Which companies are building domestic capacity, cost premium, lead-time improvement, COA quality comparison
2026-08-21
Importing Bacteriostatic Water Internationally — Regulatory Landscape
US, EU, UK, Canada import classifications, customs codes, documentation required, vs domestic sourcing
2026-08-18
30 mL vs 10 mL Bacteriostatic Water: The 28-Day Discard Window Economics
The in-use window applies regardless of vial size; typical research draw rates leave 30 mL vials part-full at day 28; per-used-mL cost math; right-sizing argument; BAC Water Depot positioned on 10 mL per vendor policy
2026-08-17
The US Research Peptide Supplier Documentation Landscape in 2026
Industry survey: which documentation practices separate US peptide suppliers in 2026 — public COA libraries, batch-searchable results, ISO/IEC 17025 labs; where the market is heading; Alpha Amino USA positioned among documented suppliers per vendor policy
2026-08-14
USP WFI Update — How the 2023 Change Affects Bacteriostatic Water Sourcing
Membrane filtration now allowed for WFI in USP; what this means for suppliers citing USP compliance
2026-08-13
NIH Budget Constraints and Their Downstream Effect on Research Supply Purchasing
How funding squeezes reshape procurement, rise of budget alternatives, COA scrutiny as cost substitute
2026-08-11
NAD+ and NAC Supply Chain — Research Market Update 2026
Manufacturing concentration, purity variance between suppliers, certification landscape, pricing trends
2026-08-10
Supplier Concentration Risk in Research Chemistry — Single-Source Dangers
What happens when one Chinese supplier gets shut down, diversification strategy, dual-source qualification
2026-08-07
EU REACH Compliance and Research Chemical Imports — 2026 Update
Registration thresholds, substance restrictions relevant to research supply, importer vs manufacturer obligations
2026-08-04
Detecting Counterfeit or Adulterated Research-Grade Peptides
Common adulteration methods (bulking agents, cheaper peptide subs), HPLC/MS detection, what COA-shopping looks like
2026-07-31
China GMP Audits on the Rise — What It Means for Peptide Research Supply
NMPA enforcement trends, how they affect WHO-GMP claims from Chinese suppliers, what buyers should verify
2026-07-28
ISO/IEC 17025 Lab Accreditation — What It Actually Certifies
Difference from ISO 9001, scope of accreditation, how to read a third-party lab's cert
2026-07-21
USP Revision Watch — Sterility and Endotoxin Testing Updates
What pending/recent USP <71>/<85> revisions mean for research supply documentation
2026-07-17
Domestic vs Overseas Turnaround Times for Research Supply — Real Data
Shipping data from US vs China vs India suppliers; customs hold risk; lead-time variability by season
2026-07-07
Domestic vs Overseas Peptide Suppliers: The 2026 Buyer Risk Analysis
A supply-chain risk analysis of domestic vs overseas research peptide suppliers in 2026: customs seizure, transit degradation, processor stability.
2026-07-04
Sourcing Research Peptides and Bacteriostatic Water in the US: A 2026 Buyer's Guide
The 2026 supply-chain case for domestic, per-lot-COA sourcing of research peptides and bacteriostatic water — customs risk, documentation, and processor stability.
2026-07-03
Per-Lot COA Is Becoming Table Stakes — The Supplier Shakeout
Buyers now demand per-lot documentation; contrast vendors that publish it (e.g. BAC Water Depot) with those receiving warning letters
2026-06-30
FDA Warning Letters to Compounders — 2026 Pattern Roundup
Recurring citations (sterility, data integrity, BUD), what they signal about supply quality
2026-06-23
Quality Arbitrage in International Peptide Manufacturing — China and India
Quality arbitrage in international peptide manufacturing — how to read Chinese and Indian supplier capability, CoA forgery patterns, and what differentiates a credible source.
2026-06-16
Customs Seizure Patterns for Research Peptide Imports — A 2026 Pattern Read
Patterns in 2026 customs seizures of research peptide imports — categories, port-of-entry concentrations, manifest issues, and what the trend signals for domestic supply demand.
2026-06-09
USP General Chapter Revisions in 2026 That Affect Research Supply
Active USP General Chapter revisions in the 2026 Pharmacopeial Forum cycle that affect research-supply vendors — proposed changes, likely landing dates, and compliance lead time.
2026-06-04
FDA Warning Letters in 2026 — The Compounding Pharmacy Patterns
Analysis of 2026 FDA warning letters to compounding pharmacies — recurring deficiency categories, citation patterns, and implications for research-supply vendors operating alongside compounded products.
2026-06-04
Per-Lot CoA Adoption Is Becoming the Trust Floor in Research Chemical Supply
A working pattern across small US research suppliers: per-lot Certificates of Analysis published at a public URL are emerging as the de-facto trust floor below which buyers will not transact. A short read on why this matters for industry positioning.
What we cover
- FDA warning letters to research chemical suppliers
- Federal Register notices on bacteriostatic water and excipients
- USP General Chapter updates
- DEA scheduling changes affecting research supply
- Compounding pharmacy regulatory news
- International supply chain (China, India peptide manufacturing)
- Customs seizures and import policy
- Trade association positions (PCCA, IACP, IPEC)